Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

A recent study published in Cell reveals that the repeated DNA sequence that leads to Huntington’s disease (HD) expands ...

Yes, Parkinson's is a disease that effects nerve cells in the brain, leading to tremors, stiffness, speech changes and more, ...

Innovative treatment for Parkinson's disease: microscopic particles combined with light therapy offer a non-surgical solution ...

The Aligning Science Across Parkinson’s (ASAP) initiative opened applications for members of the research community to apply to join the Collaborative Research Network (CRN) 2025 Scientific Track. The ...

The new Scientific Track grants will support collaborative research teams focused on dissecting the mechanisms that contribute to Parkinson’s disease (PD) heterogeneity across one of six focus ...

Parkinson’s disease (PD) may lead to an increased risk of developing ... Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment. Front Neurol. 2024 ...

Introduction: Parkinson’s disease (PD) is characterized by progressive neurodegeneration ... (L-DOPA), the precursor for dopamine synthesis, exacerbating the pathogenesis of PD and impairing synaptic ...